These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10961468)

  • 21. Study of potassium phytate effects on decreasing urinary calcium in rats.
    Grases F; Perelló J; Simonet BM; Prieto RM; García-Raja A
    Urol Int; 2004; 72(3):237-43. PubMed ID: 15084770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial.
    Nouvenne A; Meschi T; Prati B; Guerra A; Allegri F; Vezzoli G; Soldati L; Gambaro G; Maggiore U; Borghi L
    Am J Clin Nutr; 2010 Mar; 91(3):565-70. PubMed ID: 20042524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian periodicity of urinary inhibitor of calcium oxalate crystallization in healthy Indians and renal stone formers.
    Singh RK; Bansal A; Bansal SK; Singh AK; Mahdi AA
    Eur Urol; 1993; 24(3):387-92. PubMed ID: 8262108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors.
    Pieras E; Costa-Bauzá A; Ramis M; Grases F
    ScientificWorldJournal; 2006 Apr; 6():2411-9. PubMed ID: 17619710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of stone disease.
    Delvecchio FC; Preminger GM
    Curr Opin Urol; 2003 May; 13(3):229-33. PubMed ID: 12692447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment.
    Grases F; Costa-Bauzá A
    Anticancer Res; 1999; 19(5A):3717-22. PubMed ID: 10625946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal agglomeration is a major element in calcium oxalate urinary stone formation.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Kidney Int; 1990 Jan; 37(1):51-6. PubMed ID: 2299809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
    Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers.
    Zhang J; Kumar S; Jayachandran M; Herrera Hernandez LP; Wang S; Wilson EM; Lieske JC
    BMC Nephrol; 2021 Jun; 22(1):204. PubMed ID: 34074247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
    Holmes RP; Knight J; Assimos DG
    Urolithiasis; 2016 Feb; 44(1):27-32. PubMed ID: 26614109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dietary intake on urinary oxalate excretion in calcium renal stone formers.
    Masai M; Ito H; Kotake T
    Br J Urol; 1995 Dec; 76(6):692-6. PubMed ID: 8535710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers.
    Fellström B; Danielson BG; Karlström B; Lithell H; Ljunghall S; Vessby B; Wide L
    Br J Urol; 1984 Jun; 56(3):263-9. PubMed ID: 6544608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium oxalate nephrolithiasis: an easy way to detect an imbalance between promoting and inhibiting factors.
    Baggio B; Gambaro G; Oliva O; Favaro S; Borsatti A
    Clin Chim Acta; 1982 Sep; 124(2):149-55. PubMed ID: 6216029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.